For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Akouos, Inc.

USPTO Granted Patents = 15

Trademarks = 11

Forward Citations = 39

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Emmanuel John Simons (15 out of 15 patents)

Robert Ng (10 out of 11 patents)

Ellen Reisinger (6 out of 6 patents)

4. Sebastian Kügler (6 out of 7 patents)

5. Hanan Al-Moyed (6 out of 6 patents)

6. Michael J McKenna (4 out of 18 patents)

7. Hao Chiang (1 out of 1 patent)

8. Danielle Lenz (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12703874 - METHODS OF TREATING HEARING LOSS USING A SECRETED TARGET PROTEIN (2026-08-11),

2. 12673116 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2026-07-07),

3. 12365726 - Anti-VEGF antibody constructs (2025-07-22),

4. 12305191 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-05-20),

5. 12275960 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2025-04-14),

6. 12264317 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2025-04-01),

7. 12226493 - Methods of treating non-syndromic sensorineural hearing loss (2025-02-18),

8. 12077783 - AAV-mediated delivery of antibodies to the inner ear (2024-09-03),

9. 12077773 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-09-03),

10. 12071627 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-08-27),

11. 11993777 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2024-05-28),

12. 11807867 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-11-07),

13. 11781145 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2023-10-10),

14. 11697801 - AAV-mediated delivery of therapeutic antibodies to the inner ear (2023-07-11),

15. 11525139 - Compositions and methods for treating non-age-associated hearing impairment in a human subject (2022-12-13),

Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, or preserve hearing. The company was founded in 2014 and is based in Boston, Massachusetts. Akouos is focused on harnessing the power of adeno-associated viruses (AAVs) to deliver gene therapies to treat hereditary hearing loss and related conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

15 Patents

#145 in Boston, MA

#1,271 in Massachusetts

#21,017 in US

#39,822 in the World

Boston, MA, United States of America

Akouos, Inc.

Forward Citations = 39

8 inventors:

Emmanuel John Simons (15 out of 15 patents)

Robert Ng (10 out of 11 patents)

Ellen Reisinger (6 out of 6 patents)

4. Sebastian Kügler (6 out of 7 patents)

5. Hanan Al-Moyed (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…